School of Medicine


Showing 1-50 of 104 Results

  • Julieta Gabiola

    Julieta Gabiola

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsIn the Philippines where hypertension and prehypertension are prevalent and medication not affordable, we are looking into prevention of hypertension through education and lifestyle modification as a practical alternatives.

  • Calyani Ganesan

    Calyani Ganesan

    Clinical Assistant Professor, Medicine - Nephrology

    BioCalyani Ganesan, MD, MS is a general nephrologist with a focused interest in improving the care of patients with kidney stone disease through comprehensive metabolic evaluation, clinical research and multidisciplinary collaboration.

  • Kristen N Ganjoo

    Kristen N Ganjoo

    Professor of Medicine (Oncology)

    Current Research and Scholarly InterestsGiant cell tumor of the bone
    Gastrointestinal stromal tumors
    Soft tissue sarcoma
    Osteosarcoma

  • Gabriel Garcia, MD

    Gabriel Garcia, MD

    Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsThe natural history of common viral liver diseases of man is poorly understood, despite the fact that chronic liver diseases of man may result in death from liver failure or hepatocellular carcinoma.

  • Patricia Garcia

    Patricia Garcia

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioPatricia Garcia, MD is a board certified gastroenterologist and clinical informaticist. She is fellowship trained in neurogastroenterology and specializes in treating disorders of gastrointestinal motility including trouble swallowing, heartburn, reflux, constipation, fecal incontinence and pelvic floor dysfunction. She is also passionate about using digital health technologies and artificial intelligence to improve clinician and care team burden and burnout.

  • Christopher Gardner

    Christopher Gardner

    Rehnborg Farquhar Professor

    Current Research and Scholarly InterestsThe role of nutrition in individual and societal health, with particular interests in: plant-based diets, differential response to low-carb vs. low-fat weight loss diets by insulin resistance status, chronic disease prevention, randomized controlled trials, human nutrition, community based studies, Community Based Participatory Research, sustainable food movement (animal rights and welfare, global warming, human labor practices), stealth health, nutrition policy, nutrition guidelines

  • Phyllis Gardner

    Phyllis Gardner

    Professor of Medicine (Clinical Pharmacology)

    Current Research and Scholarly InterestsIon channels and signal transduction; patch clamp and fluorometric analysis; cell and molecular biology; cystic fibrosis gene therapy.

  • Benny Gavi, MD, MTS

    Benny Gavi, MD, MTS

    Clinical Assistant Professor, Medicine

    Current Research and Scholarly InterestsHospitalist Medicine
    Medicine Consultation
    Quality Improvement
    Medical Ethics
    Organizational Ethics
    Medical Humanities

  • Xiyu Ge

    Xiyu Ge

    Postdoctoral Scholar, Endocrinology, Gerontology, and Metabolism

    BioDr. Xiyu Ge is a postdoctoral fellow working with Dr. Joy Y. Wu at Stanford University School of Medicine, Division of Endocrinology, Gerontology and Metabolism. Dr. Ge obtained her Ph.D. degree from University of Illinois Urbana-Champaign, mentored by Dr. Lori T. Raetzman. At Stanford, Dr. Ge's research interests focus on single cell profiling and multi-omics analysis of bone marrow microenvironment under regulation of parathyroid hormone receptor signaling.

  • Pascal Geldsetzer

    Pascal Geldsetzer

    Assistant Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health

    BioPascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Department of Biomedical Data Science, Department of Health Policy, King Center for Global Development, and the Stanford Centers for Population Health Sciences, Innovation in Global Health, and Artificial Intelligence in Medicine & Imaging.

    His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological emphasis lies on the use of quasi-experimental approaches to ascertain causal effects in large observational datasets, particularly in electronic health record data. He has won an NIH New Innovator Award (in 2022), a Chan Zuckerberg Biohub investigatorship (in 2022), and two NIH R01 grants as Principal Investigator (both in 2023).

  • Linda N. Geng, MD, PhD

    Linda N. Geng, MD, PhD

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsMy scholarly interests are focused on defining, studying, and improving patients' diagnostic journeys. What prolongs the journey to the correct diagnosis and how can we shorten it? With this question in mind, we are exploring crowdsourcing, informatics/AI, health data visualization, and advanced laboratory testing as ways to help tackle the toughest cases in medicine-- complex, rare, and mystery conditions.

    With the COVID pandemic, the puzzling and complex illness of post-acute COVID-19 syndrome (PACS) or long COVID came to light. Together with a multidisciplinary group of physicians and researchers, we launched a program here at Stanford to advance the care and understanding of PACS. Our goal is to better understand the natural history, clinical symptomatology, immunological response, risk factors, and subgroup stratification for PACS. We are also actively assessing management strategies that may be effective for heterogeneous PACS symptoms.

  • Mark Genovese

    Mark Genovese

    James W. Raitt M.D. Professor, Emeritus

    Current Research and Scholarly InterestsClinical trials and interventions in the rheumatic diseases including Rheumatoid Arthritis,Systemic Lupus Erythematosus, Systemic Sclerosis, Osteoarthritis.

  • Daniel Aaron Gerber, MD

    Daniel Aaron Gerber, MD

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Gerber is a critical care cardiologist and co-director of Stanford's Cardiac ICU. He has dual subspecialty training in cardiovascular and critical care medicine and additional board certification in echocardiography. He completed his residency in internal medicine, fellowship in cardiovascular medicine, and an additional fellowship in critical care medicine at Stanford University and joined as faculty in 2021 as a Clinical Assistant Professor in the Department of Medicine’s Division of Cardiovascular Medicine.

    Dr. Gerber manages the full spectrum of heart and vascular conditions with a focus on critically ill patients with life-threatening cardiovascular disease. He is active in medical education, teaching introductory echocardiography to Stanford medical students and residents, co-directing the Stanford Critical Care Medicine Critical Care Ultrasound Program, and lecturing nationally on critical care echocardiography and point-of-care ultrasonography at the Society of Critical Care Medicine’s annual congress. Finally, Dr. Gerber’s research interests focus on optimizing cardiac intensive care, including working with the Critical Care Cardiology Trials Network (CCCTN) - a national network of tertiary cardiac ICUs coordinated by the TIMI Study Group - and studying acute mechanical circulatory support techniques to improve patient outcomes and care processes.

  • Neil Gesundheit

    Neil Gesundheit

    Senior Associate Dean for Medical Education, George DeForest Barnett Founders Professor of Medicine and Professor (Teaching) of Medicine (Endocrinology)

    Current Research and Scholarly InterestsOur medical education research group is developing and validating the best educational practices to train competent, compassionate, and ethical physicians and physician-scientists. We are studying the use of standardized patients and other modalities to improve clinical skill training and reasoning. We are interested in applying the rigor of clinical investigation to education research.

    My areas of clinical interest in endocrinology include disorders of the pituitary, thyroid, and gonad.

  • Olivier Gevaert

    Olivier Gevaert

    Associate Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science

    Current Research and Scholarly InterestsMy lab focuses on biomedical data fusion: the development of machine learning methods for biomedical decision support using multi-scale biomedical data. We primarily use methods based on regularized linear regression to accomplish this. We primarily focus on applications in oncology and neuroscience.

  • Karleen Giannitrapani

    Karleen Giannitrapani

    Assistant Professor of Medicine (Primary Care and Population Health)

    BioIn contrast to bounded teams with static membership, dynamic teaming reflects the common challenge of interdisciplinary healthcare teams with changing rosters. Such dynamic collaboration is critical to addressing multi-faceted problems and individualizing care. At present, off the shelf interventions to improve the way healthcare teams work - often assume static and bounded teams. Dr Giannitrapani intends to leverage design approaches to build a new kind of healthcare “teaming intervention,” which respects the nature of their constantly changing membership and more closely aligns with how healthcare teams actually collaborate. Their expertise includes organizational behavior, building interdisciplinary teams, implementation science, mixed methods-research, quality improvement, pain and palliative care research, and global health.

    In addition to the Assistant Professor role in Division of Primary Care and Population Health at Stanford University School of Medicine they serve as the quality lead for the section of Palliative Medicine. They are also a Core Investigator at the Center for Innovation to Implementation (Ci2i) in the VA Palo Alto Health Care System and serve as PI or co-investigator on multiple ongoing studies representing over 25 million dollars of competitive government grant funding. They are also a Director of the VA Quality Improvement Resource Center (QuIRC) for Palliative Care, supporting Geriatrics and Extended Care programs for 170 Veterans Affairs facilities nationally. In QuIRC they lead a portfolio of projects on improving the processes that interdisciplinary teams can leverage to improve pain and symptom management among high-risk patients; a specific focus of their work is to bridge the gap of poor palliative care integration in the perioperative period.

    They have given hundreds of presentations and have over 70 peer reviewed publications in high quality medical and health services delivery journals such as Medical Care, JAMA Surgery, the Journal of General Internal Medicine, the Journal of Pain and Symptom Management and Pain Medicine. They received a 5-year VA Career Development Award on building better teams across disciplines and was an American Academy of Hospice and Palliative Medicine Research Scholar for related work.

  • Joshua Gillard

    Joshua Gillard

    Postdoctoral Scholar, Cardiovascular Medicine

    BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, proteomics data) derived from human observational or intervention studies (vaccination and experimental human infection) in order to discover molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is focused on the use of deep learning and transformer models to identify novel splice isoforms of hypertrophic cardiomyopathy using whole genome sequencing data.

  • Christophe Gimmler, MD, MFT

    Christophe Gimmler, MD, MFT

    Clinical Assistant Professor (Affiliated), Primary Care and Population Health

    BioChristophe Gimmler, MD, MFT, Assistant Clinical Professor of Medicine (Affiliated) at Stanford School of Medicine;
    Staff Physician, Medical Service, VA Palo Alto Health Care System;
    Licensed Marriage and Family Therapist.
    _____________________________________________________________________________________________

    After establishing and building the hospitalist and consult/liaison medicine service at the VA, Christophe now practices and teaches medical students and house staff in the primary care clinics there. He concurrently practices as a community psychotherapist and specializes in medical professionals. His central interest is the intersection of medicine and psychotherapy and, in particular, the application of psychological frameworks and skills to the practice of medicine, in addition to resiliency and burnout prevention. He developed the Medical Student Resiliency Skills Training program (MedReST) for the Stanford School of Medicine as well as the Resiliency Curriculum Series for the internal medicine residency program. He received as undergraduate degree in biology and psychology and an MD from the University of Virginia, completed his internal medicine residency at Stanford, and received a Master’s in Counseling Psychology from Sofia University.

    Publications:
    Foster Well-being Throughout the Career Trajectory: A Developmental Model of Physician Resilience Training:
    Mayo Clinic Proceedings
    Cordova MJ, Gimmler CE, Osterberg LG
    2020; 95 (12):

    Developing institutional infrastructure for physician wellness: qualitative Insights from VA physicians.
    BMC Health Services Research
    Schwartz, R., Shanafelt, T. D., Gimmler, C., Osterberg, L.
    2020; 20 (1): 7

  • Alan M Glaseroff

    Alan M Glaseroff

    Adjunct Professor, Medicine - Primary Care and Population Health

    BioDr. Alan Glaseroff served as the Director of Workforce Transformation in Primary Care at Stanford from the fall of 2015 until mid-June of 2016, where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care underway in 2016. He will be joining the faculty at Stanford's Clinical Excellence Research Center this summer, working with Dr. Arnie Milstein to help develop new models of care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness from 2011 to the end of 2015. Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative and served as a a Clinical Advisor to the PBGH “Intensive Outpatient Care Program” CMMI Innovation Grant that completes in June 2015. He served on the NCQA Patient-Centered Medical Home Advisory Committee 2009-2010, and the “Let’s Get Healthy California” expert task force in 2012,. Dr. Glaseroff was named the California Family Physician of the Year for 2009.

    Dr. Glaseroff’s interests focus on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.

    The Coordinated Care clinic is an exclusive benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions.

    Please complete the Coordinated Care self-assessment to determine eligibility based on health condition(s) and health insurance: https://stanfordmedicine.qualtrics.com/SE/?SID=SV_2siBNrfJ8zmn3GB

  • Jeffrey S.  Glenn, M.D., Ph.D.

    Jeffrey S. Glenn, M.D., Ph.D.

    Joseph D. Grant Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.

  • Thomas Glynn

    Thomas Glynn

    Adjunct Lecturer, Med/Stanford Prevention Research Center

    BioBiosketch - Thomas J. Glynn, M.A., M.S., Ph.D. (psych.)

    Dr. Glynn is, from 2014 to the present, Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine and Executive Team Member, Mayo Clinic Global Bridges Initiative. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policies, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.

    Prior to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute's (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI's Cancer Control Extramural Research Branch. There, he directed a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI's Smoking, Tobacco, and Cancer Program and from 1978 to 1983, he was a Research Psychologist at the National Institute on Drug Abuse.

    Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education and is co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, the WHO, a variety of pharmaceutical organizations, and national, state and local governments.

    He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General's Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. He is a Fellow of the Society for Research on Nicotine and Tobacco and his awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award.

  • Aparna Goel

    Aparna Goel

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsDr. Goel is interested in studying the complications and management of patients with end-stage liver disease, including infections, bleeding and encephalopathy. As the waitlist for liver transplantation continues to grow, many patients develop consequences of decompensated liver disease. It is becoming increasingly important to improve our understanding and care of these complications in order to optimize the quality of life for this growing population of patients.

    She is also particularly interested in the management of patients with autoimmune liver disease including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis among others.

  • Sneha Goenka

    Sneha Goenka

    Postdoctoral Scholar, Cardiovascular Medicine
    Ph.D. Student in Electrical Engineering, admitted Autumn 2017
    Stanford Student Employee, Hoover Institution

    BioSneha Goenka is a Ph.D. candidate in the Electrical Engineering Department at Stanford University where she is advised by Prof. Mark Horowitz. Her research centers on designing efficient computer systems for advancing genomic pipelines for clinical and research applications, with a focus on improving speed and cost. She is a 2023 Forbes 30 Under 30 Honoree in the Science category, 2022 NVIDIA Graduate Fellow, and 2021 Cadence Women in Technology Scholar. She has a B.Tech. and M.Tech. (Microelectronics) in Electrical Engineering from the Indian Institute of Technology, Bombay where she received the Akshay Dhoke Memorial Award for the most outstanding student in the program.

  • Amit Gohil

    Amit Gohil

    Clinical Associate Professor (Affiliated), Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
    Staff, Medicine - Med/Pulmonary, Allergy & Critical Care Medicine

    BioMy main practice is at County Hospital of Santa Clara, where my time is split between Pulmonary Clinic, Pulmonary Physiology Lab and Medical Intensive Care.

    Other Clinical Interests include neurocritical care, Mab therapy for asthma,. and management of toxin induced pulmonary hypertension

    My research interests are moving into the use of Data Science to answer clinical questions. I am currently in the process of becoming familiar with R as a coding language to examine large clinical data sets and hope to move into machine learning algorithms to improve the pulmonary health of our county population.